Global Immuno-Oncology Treatment Market Status and Outlook 2024-2029
Global Immuno-Oncology Treatment Market Status and Outlook 2024-2029
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease. It is an application of the fundamental research of cancer immunology and a growing subspeciality of oncology.
Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.
We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.
The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.
We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.
The report will conduct a comprehensive and professional analysis of the Immuno-Oncology Treatment market in 2024 based on the current situation, global economic impact and other aspects.
Market Segment by Product Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Market Segment by Product Application
Hospitals
Ambulatory Surgical Center
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen
Merck
Eli-Lilly
AstraZeneca
Janssen Biotech
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Roche
Novartis
Sanofi
Spectrum Pharmaceuticals
Takeda
Insights and Tools:
This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.
The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.
Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To define, describe and forecast the Immuno-Oncology Treatment market by type, application, end user and region
2.Provide enterprise external environment analysis and SWOT analysis
3.Focuses on the key global Immuno-Oncology Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.
4.Provide market entry strategy analysis for new players or players preparing to enter the market
5.Keep up with international market trends and analyze the impact of the important international events on major global regions
6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape
Global Immuno-Oncology Treatment Market Status and Outlook 2024-2029
Market Study Overview
1.1 Study Objectives
1.2 Immuno-Oncology Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Immuno-Oncology Treatment Segment by Type
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Monoclonal Antibodies
2.1.3 Cytokine-Based Immunotherapy
2.1.4 Cancer Vaccines
2.1.5 CAR-T Cell Therapy
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Ambulatory Surgical Center
2.2.3 Others
2.3 Global Immuno-Oncology Treatment Market Comparison by Regions (2019-2029)
2.3.1 Global Immuno-Oncology Treatment Market Size (2019-2029)
2.3.2 North America Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.3 Europe Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.4 Asia-pacific Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.5 South America Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.3.6 Middle East & Africa Immuno-Oncology Treatment Status and Prospect (2019-2029)
2.5 Coronavirus Disease 2020 (Covid-19): Immuno-Oncology Treatment Industry Impact
2.5.1 Immuno-Oncology Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Immuno-Oncology Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Vendors
3.1 Global Immuno-Oncology Treatment Revenue and Market Share by Vendors (2019-2024)
3.2 Global Immuno-Oncology Treatment Industry Concentration Ratio (CR5 and HHI)
3.3 Top 5 Immuno-Oncology Treatment Vendors Market Share
3.4 Top 10 Immuno-Oncology Treatment Vendors Market Share
3.5 Date of Key Vendors Enter into Immuno-Oncology Treatment Market
3.6 Key Vendors Immuno-Oncology Treatment Product Offered
3.7 Mergers & Acquisitions Planning
4 Analysis of Immuno-Oncology Treatment Industry Key Vendors
4.1 Amgen
4.1.1 Company Details
4.1.2 Product Introduction, Application and Specification
4.1.3 Amgen Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.1.4 Main Business Overview
4.1.5 Amgen News
4.2 Merck
4.2.1 Company Details
4.2.2 Product Introduction, Application and Specification
4.2.3 Merck Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.2.4 Main Business Overview
4.2.5 Merck News
4.3 Eli-Lilly
4.3.1 Company Details
4.3.2 Product Introduction, Application and Specification
4.3.3 Eli-Lilly Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.3.4 Main Business Overview
4.3.5 Eli-Lilly News
4.4 AstraZeneca
4.4.1 Company Details
4.4.2 Product Introduction, Application and Specification
4.4.3 AstraZeneca Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.4.4 Main Business Overview
4.4.5 AstraZeneca News
4.5 Janssen Biotech
4.5.1 Company Details
4.5.2 Product Introduction, Application and Specification
4.5.3 Janssen Biotech Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.5.4 Main Business Overview
4.5.5 Janssen Biotech News
4.6 Bristol-Myers Squibb
4.6.1 Company Details
4.6.2 Product Introduction, Application and Specification
4.6.3 Bristol-Myers Squibb Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.6.4 Main Business Overview
4.6.5 Bristol-Myers Squibb News
4.7 Pfizer
4.7.1 Company Details
4.7.2 Product Introduction, Application and Specification
4.7.3 Pfizer Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.7.4 Main Business Overview
4.7.5 Pfizer News
4.8 GlaxoSmithKline
4.8.1 Company Details
4.8.2 Product Introduction, Application and Specification
4.8.3 GlaxoSmithKline Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.8.4 Main Business Overview
4.8.5 GlaxoSmithKline News
4.9 Roche
4.9.1 Company Details
4.9.2 Product Introduction, Application and Specification
4.9.3 Roche Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.9.4 Main Business Overview
4.9.5 Roche News
4.10 Novartis
4.10.1 Company Details
4.10.2 Product Introduction, Application and Specification
4.10.3 Novartis Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.10.4 Main Business Overview
4.10.5 Novartis News
4.11 Sanofi
4.11.1 Company Details
4.11.2 Product Introduction, Application and Specification
4.11.3 Sanofi Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.11.4 Main Business Overview
4.11.5 Sanofi News
4.12 Spectrum Pharmaceuticals
4.12.1 Company Details
4.12.2 Product Introduction, Application and Specification
4.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.12.4 Main Business Overview
4.12.5 Spectrum Pharmaceuticals News
4.13 Takeda
4.13.1 Company Details
4.13.2 Product Introduction, Application and Specification
4.13.3 Takeda Immuno-Oncology Treatment Gross Margin, and Revenue (2019-2024)
4.13.4 Main Business Overview
4.13.5 Takeda News
5 Global Immuno-Oncology Treatment Market Size Categorized by Regions
5.1 Global Immuno-Oncology Treatment Revenue and Market Share by Regions
5.2 North America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.3 Europe Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.4 Asia-pacific Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.5 South America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
5.6 Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6 North America Immuno-Oncology Treatment Market Size Categorized by Countries
6.1 North America Immuno-Oncology Treatment Revenue and Market Share by Countries
6.1.1 North America Immuno-Oncology Treatment Market Size by Countries (2019-2024)
6.1.2 United States Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6.1.3 Canada Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6.1.4 Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
6.2 North America Immuno-Oncology Treatment Revenue (Value) by Vendors
6.3 North America Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
6.4 North America Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
7 Europe Immuno-Oncology Treatment Market Size Categorized by Countries
7.1 Europe Immuno-Oncology Treatment Revenue and Market Share by Countries
7.1.1 Europe Immuno-Oncology Treatment Market Size by Countries (2019-2024)
7.1.2 Germany Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.3 UK Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.4 France Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.5 Russia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.6 Italy Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.1.7 Spain Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
7.2 Europe Immuno-Oncology Treatment Revenue (Value) by Vendors
7.3 Europe Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
7.4 Europe Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
8 Asia-pacific Immuno-Oncology Treatment Market Size Categorized by Countries
8.1 Asia-pacific Immuno-Oncology Treatment Revenue and Market Share by Countries
8.1.1 Asia-pacific Immuno-Oncology Treatment Market Size by Countries (2019-2024)
8.1.2 China Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.3 South Korea Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.4 Japan Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.5 Australia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.6 India Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.1.7 Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
8.2 Asia-pacific Immuno-Oncology Treatment Revenue (Value) by Vendors
8.3 Asia-pacific Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
8.4 Asia-pacific Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
9 South America Immuno-Oncology Treatment Market Size Categorized by Countries
9.1 South America Immuno-Oncology Treatment Revenue and Market Share by Countries
9.1.1 South America Immuno-Oncology Treatment Market Size by Countries (2019-2024)
9.1.2 Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
9.1.3 Chile Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
9.2 South America Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
9.3 South America Immuno-Oncology Treatment Revenue and Market Share by Application (2019-2024)
10 Middle East and Africa Immuno-Oncology Treatment Market Size Categorized by Countries
10.1 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Countries
10.1.1 Middle East and Africa Immuno-Oncology Treatment Market Size by Countries (2019-2024)
10.1.2 GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.1.3 Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.1.4 Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.1.5 South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
10.2 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Type
10.3 Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Application (2019-2024)
11 Global Immuno-Oncology Treatment Market Segment by Type
11.1 Global Immuno-Oncology Treatment Revenue and Market Share by Type (2019-2024)
11.2 Immune Checkpoint Inhibitors Revenue Growth Rate and Price
11.3 Monoclonal Antibodies Revenue Growth Rate and Price
11.4 Cytokine-Based Immunotherapy Revenue Growth Rate and Price
11.5 Cancer Vaccines Revenue Growth Rate and Price
11.6 CAR-T Cell Therapy Revenue Growth Rate and Price
12 Global Immuno-Oncology Treatment Market Segment by Application
12.1 Global Immuno-Oncology Treatment Revenue Market Share by Application (2019-2024)
12.2 Hospitals Revenue Growth Rate (2019-2024)
12.3 Ambulatory Surgical Center Revenue Growth Rate (2019-2024)
12.4 Others Revenue Growth Rate (2019-2024)
13 Global Immuno-Oncology Treatment Market Forecast
13.1 Global Immuno-Oncology Treatment Revenue and Growth Rate (2024-2029)
13.2 Immuno-Oncology Treatment Market Forecast by Regions (2024-2029)
13.2.1 North America Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.2 Europe Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.3 Asia-Pacific Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.4 South America Immuno-Oncology Treatment Market Forecast (2024-2029)
13.2.5 Middle East & Africa Immuno-Oncology Treatment Market Forecast (2024-2029)
13.3 Immuno-Oncology Treatment Market Forecast by Type (2024-2029)
13.3.1 Global Immuno-Oncology Treatment Revenue Forecast by Type (2024-2029)
13.3.2 Global Immuno-Oncology Treatment Market Share Forecast by Type (2024-2029)
13.4 Immuno-Oncology Treatment Market Forecast by Application (2024-2029)
13.4.1 Global Immuno-Oncology Treatment Revenue Forecast by Application (2024-2029)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Downstream Market Analysis
15.1 Macro Analysis of Down Markets
15.2 Key Players in Down Markets
16 Research Findings and Conclusion
Tables & Figures:
List of Tables and Figures
Figure Product Picture Immuno-Oncology Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Immuno-Oncology Treatment Market Size (Million US$) by Type
Figure Global Market Share of Immuno-Oncology Treatment by Type in 2023
Figure Immune Checkpoint Inhibitors Picture
Figure Monoclonal Antibodies Picture
Figure Cytokine-Based Immunotherapy Picture
Figure Cancer Vaccines Picture
Figure CAR-T Cell Therapy Picture
Table Global Immuno-Oncology Treatment Market Size (Million US$) by Application
Figure Global Immuno-Oncology Treatment Market Share by Application in 2023
Figure Hospitals Picture
Figure Ambulatory Surgical Center Picture
Figure Others Picture
Table Global Immuno-Oncology Treatment Comparison by Regions (M USD) 2019-2029
Figure Global Immuno-Oncology Treatment Market Size (Million US$) (2019-2029)
Figure North America Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure Europe Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure Asia-pacific Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure South America Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Figure Middle East & Africa Immuno-Oncology Treatment Revenue (Million US$) Growth Rate (2019-2029)
Table Business Impact Assessment - Covid-19
Table Market Trends and Immuno-Oncology Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Immuno-Oncology Treatment Revenue by Vendors (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table Global Immuno-Oncology Treatment Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2023
Figure Top 10 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2023
Table Date of Key Vendors Enter into Immuno-Oncology Treatment Market
Table Key Vendors Immuno-Oncology Treatment Product Type
Table Amgen Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Amgen
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Amgen 2019-2024
Table Amgen Main Business
Table Amgen Recent Development
Table Merck Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Merck
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Merck 2019-2024
Table Merck Main Business
Table Merck Recent Development
Table Merck Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Merck
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Merck 2019-2024
Table Merck Main Business
Table Merck Recent Development
Table Eli-Lilly Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Eli-Lilly
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Eli-Lilly 2019-2024
Table Eli-Lilly Main Business
Table Eli-Lilly Recent Development
Table AstraZeneca Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of AstraZeneca
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of AstraZeneca 2019-2024
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Janssen Biotech Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Janssen Biotech
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Janssen Biotech 2019-2024
Table Janssen Biotech Main Business
Table Janssen Biotech Recent Development
Table Bristol-Myers Squibb Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2019-2024
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Pfizer Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Pfizer
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Pfizer 2019-2024
Table Pfizer Main Business
Table Pfizer Recent Development
Table GlaxoSmithKline Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of GlaxoSmithKline
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of GlaxoSmithKline 2019-2024
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Roche Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Roche
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Roche 2019-2024
Table Roche Main Business
Table Roche Recent Development
Table Novartis Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Novartis
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Novartis 2019-2024
Table Novartis Main Business
Table Novartis Recent Development
Table Sanofi Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Sanofi
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Sanofi 2019-2024
Table Sanofi Main Business
Table Sanofi Recent Development
Table Spectrum Pharmaceuticals Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Spectrum Pharmaceuticals
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Spectrum Pharmaceuticals 2019-2024
Table Spectrum Pharmaceuticals Main Business
Table Spectrum Pharmaceuticals Recent Development
Table Takeda Company Profile
Table Immuno-Oncology Treatment Product Introduction, Application and Specification of Takeda
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin of Takeda 2019-2024
Table Takeda Main Business
Table Takeda Recent Development
Table Mergers & Acquisitions Planning
Figure Global Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue by Regions (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Regions in 2023
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Asia-pacific Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table North America Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table North America Immuno-Oncology Treatment Market Share by Countries (2019-2024)
Figure North America Immuno-Oncology Treatment Market Share by Countries in 2023
Figure United States Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Canada Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table North America Immuno-Oncology Treatment Revenue by Vendors (2023)
Figure North America Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table North America Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table North America Immuno-Oncology Treatment Share by Type (2019-2024)
Table North America Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table North America Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Europe Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue Market Share by Countries (2019-2024)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Countries in 2023
Figure Germany Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure UK Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure France Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Russia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Italy Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Spain Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue by Vendors (2023)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table Europe Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Europe Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure Asia-pacific Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue Market Share by Countries (2019-2024)
Figure Asia-pacific Immuno-Oncology Treatment Revenue Market Share by Countries in 2023
Figure China Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure South Korea Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Japan Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Australia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure India Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue by Vendors (2023)
Figure Asia-pacific Immuno-Oncology Treatment Revenue Market Share by Vendors in 2023
Table Asia-pacific Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Asia-pacific Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Market Size by Countries (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Market Share by Countries (2019-2024)
Figure South America Immuno-Oncology Treatment Revenue Market Share by Countries in 2023
Figure Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Chile Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table South America Immuno-Oncology Treatment Revenue s by Type (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table South America Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table South America Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Market Size by Countries (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Sales Market Share by Countries (2019-2024)
Figure Middle East and Africa Immuno-Oncology Treatment Sales Market Share by Countries in 2023
Figure GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Figure South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Type (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Application (2019-2024)
Table Global Immuno-Oncology Treatment Revenue by Type (2019-2024)
Table Global Immuno-Oncology Treatment Revenue Market Share by Type (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Type in 2023
Figure Global Immune Checkpoint Inhibitors Revenue and Growth Rate (2019-2024)
Figure Global Monoclonal Antibodies Revenue and Growth Rate (2019-2024)
Figure Global Cytokine-Based Immunotherapy Revenue and Growth Rate (2019-2024)
Figure Global Cancer Vaccines Revenue and Growth Rate (2019-2024)
Figure Global CAR-T Cell Therapy Revenue and Growth Rate (2019-2024)
Table Global Immuno-Oncology Treatment Revenue by Application (2019-2024)
Table Global Immuno-Oncology Treatment Revenue Market Share by Application (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Application in 2023
Figure Global Hospitals Revenue Growth Rate (2019-2024)
Figure Global Ambulatory Surgical Center Revenue Growth Rate (2019-2024)
Figure Global Others Revenue Growth Rate (2019-2024)
Figure Global Immuno-Oncology Treatment Revenue and Growth Rate (2024-2029)
Table Global Immuno-Oncology Treatment Revenue Forecast by Regions (2024-2029)
Table Global Immuno-Oncology Treatment Market Share Forecast by Regions (2024-2029)
Figure North America Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure Europe Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure Asia-Pacific Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure South America Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Figure Middle East & Africa Revenue Immuno-Oncology Treatment Market Forecast (2024-2029)
Table Global Immuno-Oncology Treatment Revenue Forecast by Type (2024-2029)
Table Global Immuno-Oncology Treatment Market Share Forecast by Type (2024-2029)
Table Global Immuno-Oncology Treatment Revenue Forecast by Application (2024-2029)
Table Global Immuno-Oncology Treatment Market Share Forecast by Application (2024-2029)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Author List
Research Methodology:
Immuno-Oncology Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|